3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Terminated
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Nasopharyngeal Carcinoma
21
Prostatic Neoplasms
8
Breast Neoplasms
7
Head and Neck Neoplasms
6
Esophageal Squamous Cell Carcinoma
6
Esophageal Neoplasms
6
Rectal Neoplasms
4
Radiation Injuries
4
Carcinoma, Squamous Cell
4
Carcinoma, Non-Small-Cell Lung
4
Neoplasm Metastasis
3
Nasopharyngeal Neoplasms
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Salivary Gland Neoplasms
2
Recurrence
2
Lung Neoplasms
2
Vulvar Neoplasms
1
Thyroid Neoplasms
1
Sinonasal undifferentiated carcinoma
1
Radiation
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ototoxicity
1
Obesity
1
Neurotoxicity Syndromes
1
Neoplasms
1
Interventions
Sorafenib
9
Radiofrequency Ablation
7
Oxaliplatin
7
Fluorouracil
6
Doxorubicin
6
Neoadjuvant Therapy
5
toripalimab
4
lenvatinib
4
Injections
4
Chemotherapy, Adjuvant
4
Bevacizumab
4
sintilimab
3
pembrolizumab
3
Ultrasonography
3
Thalidomide
3
Leucovorin
3
Irinotecan
3
Cisplatin
3
tislelizumab
2
durvalumab
2
camrelizumab
2
anlotinib
2
Walking Speed
2
Standard of Care
2
Radiosurgery
2
Oncolytic Virotherapy
2
Metformin
2
Liver Transplantation
2
Laparoscopy
2
Immunohistochemistry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Liver Neoplasms
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT05339581
2022-04-27
iPLENTY-pvtt
RenJi Hospital
Phase NA
Unknown
78 enrolled